Repligen (RGEN) Cash from Investing Activities (2010 - 2026)

Repligen (RGEN) reported Cash from Investing Activities of -$4.0 million for Q1 2026, up 94.62% year-over-year from -$2.0 million in Q1 2025, and up 98.09% quarter-over-quarter from -$208.7 million in Q4 2025.

Repligen (RGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Repligen (RGEN) has 17 years of Cash from Investing Activities data on file, last reported at -$4.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$4.0 million, up 94.62% year-over-year; the trailing twelve-month figure through Mar 2026 was -$228.4 million (down 50.11% YoY), and the FY2025 annual result was -$298.5 million, down 245.52% from the prior year.
  • Cash from Investing Activities improved to -$4.0 million in Q1 2026 per RGEN's latest filing, from -$208.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $64.8 million in Q2 2023 and troughed at -$208.7 million in Q4 2025.
  • A 5-year average of -$43.8 million and a median of -$9.4 million in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities surged 347.27% in 2023, then sank 786.25% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$121.3 million in 2022, then sank by 40.06% to -$169.9 million in 2023, then jumped by 61.88% to -$64.8 million in 2024, then plunged by 222.32% to -$208.7 million in 2025, then jumped by 98.09% to -$4.0 million in 2026.
  • Business Quant data shows RGEN's Cash from Investing Activities at -$4.0 million in Q1 2026, -$208.7 million in Q4 2025, and -$7.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Repligen 7.41 Bn 6.42 Bn 108.28 Mn -3.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.99 Mn
Mar 31, 2026 -3.99 Mn
Dec 31, 2025 -208.74 Mn
Dec 31, 2025 -208.74 Mn
Sep 30, 2025 -7.78 Mn
Sep 30, 2025 -7.78 Mn
Jun 30, 2025 -7.84 Mn
Jun 30, 2025 -7.84 Mn
Mar 31, 2025 -74.11 Mn
Mar 31, 2025 -74.11 Mn
Dec 31, 2024 -64.76 Mn
Dec 31, 2024 -64.76 Mn
Sep 30, 2024 -5.86 Mn
Sep 30, 2024 -5.86 Mn
Jun 30, 2024 -7.40 Mn
Jun 30, 2024 -7.40 Mn
Mar 31, 2024 -8.36 Mn
Mar 31, 2024 -8.36 Mn
Dec 31, 2023 -169.91 Mn
Dec 31, 2023 -169.91 Mn